Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2039 | Panaxydol | cAMP; p38 MAPK; JNK | GPCR/G Protein; MAPK |
Panaxydol has anti-cancer activity, can inhibit the growth and apoptosis of cancer cells, the signaling mechanisms involve a [Ca(2+)](i) increase, JNK and p38 MAPK activation, cAMP, MAP kinase and ROS generation through NADPH oxidase and mitochondria. |